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Strengths and limitations of this study
 ► This pilot factorial randomised controlled trial ad-
dressed whether a main trial of wound dressing 
strategies was possible.
 ► The factorial design examined whether intraopera-
tive randomisation was acceptable and feasible.
 ► Surgical trainee collaboratives and research nurse 
teams worked together to optimise recruitment.
 ► Temporary skin transfers adjacent to the surgical 
wound supported adherence to dressing allocation.
 ► Follow- up questionnaire response rates were low 
and need optimisation in a main trial.
AbStrACt
Objective Surgical site infection (SSI) affects up to 25% 
of primary surgical wounds. Dressing strategies may 
influence SSI risk. The Bluebelle study assessed the 
feasibility of a multicentre randomised controlled trial 
(RCT) to evaluate the effectiveness and cost- effectiveness 
of different dressing strategies to reduce SSI in primary 
surgical wounds.
Design A pilot, factorial RCT.
Setting Five UK hospitals.
Participants Adults undergoing abdominal surgery with a 
primary surgical wound.
Interventions Participants were randomised to ‘simple 
dressing’, ‘glue- as- a- dressing’ or ‘no dressing’, and to the 
time at which the treatment allocation was disclosed to the 
surgeon (disclosure time, before or after wound closure).
Primary and secondary outcome measures Feasibility 
outcomes focused on recruitment, adherence to 
randomised allocations, reference assessment of SSI and 
response rates to participant- completed and observer- 
completed questionnaires to assess SSI (proposed primary 
outcome for main trial), wound experience and symptoms, 
and quality of life (EQ- 5D- 5L).
results Between March and November 2016, 1115 
patients were screened; 699 (73.4%) were eligible and 
approached, 415 (59.4%) consented and 394 (35.3%) 
were randomised (simple dressing=133, glue=129 and ‘no 
dressing’=132). Non- adherence to dressing allocation was 
2% (3/133), 6% (8/129) and 15% (20/132), respectively. 
Adherence to disclosure time was 99% and 86% before 
and after wound closure, respectively. The overall rate 
of SSI (reference assessment) was 18.1% (51/281). 
Response rates to the Wound Healing Questionnaire and 
other questionnaires ranged from >90% at 4 days to 68% 
at 4–8 weeks.
Conclusions A definitive RCT of dressing strategies 
including ‘no dressing’ is feasible. Further work is needed 
to optimise questionnaire response rates.
trial registration number 49328913; Pre- results.
IntrODuCtIOn
Each year, there are over 5 million hospital 
admissions for surgery in England alone.1 
The majority result in ‘a closed primary 
wound’ and it is common practice to cover 
these with a dressing. Despite attempts to 
minimise infection, many develop a surgical 
site infection (SSI). This is especially prob-
lematic in abdominal surgery and high- risk 
settings where rates of SSI may reach 25%.2 3 
SSIs require antibiotics and multiple dress-
ings, can delay recovery, reduce quality of life 
and are expensive for health services.4 5
Abdominal surgery carries one of the 
highest rates of SSI, particularly if the opera-
tion involves the colon or rectum.3 6 Caesarean 
section is another procedure which carries a 
high rate of SSI.7 Possible ways to reduce SSI 
include modification of preoperative, periop-
erative and postoperative factors, which 
include optimising wound dressing strategies 
and examining whether dressings are needed 
at all. A Cochrane review of randomised 
controlled trials (RCTs) examining different 
dressing strategies, which included studies of 
wounds without a dressing, was performed 
in 2011 and since updated.8–10 The initial 
review found no difference in rates of SSI 
between wounds covered with different dress-
ings or left uncovered. The update found 
insufficient evidence to reach a firm conclu-
sion. Most trials included in the review were 
small and at high or unclear risk of bias. A 
subsequent Cochrane review of intraopera-
tive methods to reduce SSI commented on 
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Figure 1 Example of a skin transfer (modelled by a 
volunteer) that was applied near to the wound(s) to promote 
adherence to the dressing allocation.
the need for more research in this field.11 In 2014, the 
UK National Institute of Health Research, therefore, 
called for research proposals to address these issues with 
feasibility and pilot work to establish if a major RCT was 
possible. The Bluebelle study, a programme of research 
including non- randomised feasibility projects (phase A) 
and a pilot RCT (phase B), was designed to inform the 
design of a main trial.12–16 Phase A included interviews 
with key stakeholders to explore their views of dress-
ings and a trial design,12 a survey of surgical wounds to 
examine current dressing practice13 and developmental 
work to design questionnaires to assess SSI15 and other 
aspects of wound management.14 Here, we report the 
pilot RCT.16 The aim of the pilot RCT was to establish 
whether it would be feasible to carry out a large definitive 
RCT to compare the effectiveness and cost- effectiveness 
of different dressing strategies to reduce SSIs following 
elective and unplanned surgery with a primary wound. 
Specific objectives were to establish if it was possible to 
recruit and randomise, to assess the acceptability of, and 
adherence to, the trial interventions, to examine the 
feasibility of collecting follow- up data and to establish the 
measurement properties of the SSI Wound Healing Ques-
tionnaire (WHQ).
MethODS
Study design
A factorial design was used to investigate adherence to the 
allocated dressing types and the feasibility of randomising 
after wound closure. Patients were randomised 1:1:1 to 
dressing type (simple dressing, glue- as- a- dressing and ‘no 
dressing’) and 1:1 to the time at which the dressing alloca-
tion was disclosed to the surgeon (revealed before or after 
wound closure details had been entered onto the study 
database). Full details of the interventions are described 
in the protocol.16 The randomisation sequences were 
generated by computer in advance of starting to recruit. 
Allocation was concealed until participant’s eligibility 
and consent were documented and it was obtained via 
the internet. Depending on the randomisation result, the 
dressing allocation was either disclosed immediately, or 
the user was advised to log back on to the website after 
the wound had been closed. At the second log- on the user 
was asked to record the timing of wound closure, then the 
allocation was disclosed. The full protocol is published 
elsewhere.16 The randomisation scheme was stratified 
by hospital and specialty (abdominal/obstetric surgery). 
The rationale for randomising to disclosure time as well 
as to dressing type was the need to understand whether 
surgeons’ knowledge of treatment allocation influ-
ences the quality of wound closure (i.e., if allocation to 
‘no dressing’ leads to surgeons taking more care with 
wound closure). It was intended to use in- theatre wound 
photography to assess quality of wound closure in rela-
tion to timing of disclosure of allocation; however, it soon 
became apparent that this outcome measure could not be 
implemented due to multiple governance and logistical 
challenges. This paper, therefore, reports the feasibility of 
conducting the pilot RCT of different dressing strategies 
and the feasibility of randomising before or after wound 
closure.
Study setting and population
The study was set in University Hospitals Bristol NHS 
Foundation Trust (Bristol Royal Infirmary and St 
Michael’s Hospital), North Bristol NHS Trust (Southmead 
Hospital), University Hospitals Birmingham NHS Foun-
dation Trust (Queen Elizabeth Hospital) and Worcester-
shire Acute Hospitals NHS Trust. Included were adult 
participants undergoing abdominal general or obstetric 
surgery with a skin incision, who were able and willing 
to provide consent and complete follow- up at 4–8 weeks. 
Excluded were people who had undergone major surgery 
within the previous 3 months, wounds that a surgeon 
planned to close with tissue glue, contraindications to 
dressing allocation and prisoners. Surgery and wound 
closure were carried out according to local practice.
Feasibility outcomes
Primary feasibility outcomes were whether patients 
were eligible, consented and recruited to the study, and 
whether they adhered to randomised allocation (yes/
no). Skin transfers (temporary adherent tattoos) were 
placed next to the wound to encourage adherence to 
allocated dressing type after leaving the operating theatre 
(figure 1). The feasibility of collecting other data (likely 
to be used in a main trial) and their completeness was 
investigated for: patient and observer reported question-
naires measuring SSI with the newly validated WHQ; 
patient and observer reported questionnaires to assess 
symptoms and experiences of wounds and dressings; 
preference- based health- related quality of life (EuroQoL- 
five- dimension- five- level: EQ- 5D- 5L) 17; wound complica-
tions and resource use.18 A face- to- face wound assessment 
was carried out at 4-6 weeks to validate the WHQ.19 This 
assessment was used in combination with data collected 
at discharge to classify each participant as having had an 
SSI or not.
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Sample size
It was calculated that 920 eligible participants would allow 
a consent rate of 36% (target number randomised=330) 
to be estimated with a 95% CI of 32% to 39%, and a 
recruitment rate of 60% with 95% CI of 56% to 64%. A 
consent rate of 36% was proposed because of previous 
experience recruiting into surgical trials. It was prespec-
ified that, if adherence to dressing type was <70% in any 
group, it would be concluded that the main trial would 
not be feasible.
Statistical analyses
Analyses were directed by a prespecified analysis plan and 
performed on an intention- to- treat basis. Continuous 
data were summarised as medians and IQRs. Categorical 
data were summarised as numbers and percentages and 
95% CIs. Results were described by centre and by specialty 
as well as overall. The primary analysis took place when 
follow- up was complete for all recruited participants. All 
analyses were performed in Stata V.14.0 (StataCorp).
understanding adherence and acceptability to treatment 
allocation
Semistructured interviews were conducted with patients 
and staff within 30 days of surgery to understand issues 
relating to adherence and acceptability of dressing strat-
egies (especially ‘no dressing’). The findings have been 
reported elsewhere.12
Patient and public involvement
Patients and the public were involved in several stages 
of this research. The initial idea came from a patient 
case study. A Bluebelle study patient and public involve-
ment group was established including patients and their 
carers. Members were involved in study design and 
set up including commenting on patient facing mate-
rials. Patient representatives were on the study steering 
committee and management group and advised on how to 
approach patients and ideas for blinding study personnel. 
Extensive pretrial feasibility work (published) examined 
the burden of the intervention and time required to 
participate in the research with qualitative research. The 
main trial will continue to include patients throughout 
all of its stages (design, delivery, analyses, reporting and 
implementation).
reSultS
recruitment and participant details
Between March and November 2016, 1115 patients were 
screened; 699 (73.4%) were eligible and approached; 
415 (37.2%) consented to take part; 394 (35.5%) were 
randomised (figure 2). The analysis population consisted 
of 388 participants (790 wounds), that is, the 394 
randomised participants excluding three participants 
who withdrew and were unhappy for their data to be 
used, two participants who were allocated to disclosure 
of dressing allocation after wound closure and whose 
randomisation in theatre was not completed, and one 
participant whose surgery was cancelled. Some patients 
were consented but not randomised after consent 
because the study ended. Feasibility outcomes by centre 
are shown in table 1. Participants were predominantly 
women (227/388, 58.5%), overweight (median body 
mass index 28, IQR 24.3–31.6), American Society of Anes-
thesia grade 2 (203/384, 52.9%) and Caucasian 341/374 
(91.2%) (table 2). Most wounds (93.7%) were closed with 
sutures and approximately three- quarters of participants 
were prescribed prophylactic antibiotics. There was no 
indication that these cointerventions were used differen-
tially by group (table 2).
Adherence to allocated treatment and timing of randomisation
Adherence to treatment allocation was good. More than 
97% of participants correctly received the allocated 
dressing in theatre with adherence after leaving theatre 
to group allocation remaining high (86%) through to 
study exit. Adherence to the time at which their surgeons 
were informed about the treatment allocation was 99% 
and 86% before and after wound closure, respectively. 
Interviews with staff and patients indicated that skin 
transfers were acceptable; nobody objected to their use 
and most nurses viewed them as useful, although some 
felt they did not personally need to use the transfers as 
adherence aids.
Follow up data
Face- to- face SSI reference assessments were performed 
in 80% of participants, among whom the overall SSI 
rate was 18.1% (table 3). Response rates for the partic-
ipant and observer completed measures of SSI (WHQ) 
were 256/378 (68%) and 286/377 (76%), respectively, 
at 4–8 weeks (table 4). Completion of in- hospital ques-
tionnaires to assess Wound Symptoms and Experiences 
was >90% (355/385). Completion of EQ- 5D- 5L ques-
tionnaires during the follow- up was 269/382 (70%) at 15 
days and 242/377 (64%) at 4–8 weeks. Wound complica-
tion data (other than SSI) were completed for 326/388 
(84%) participants during the postoperative hospital stay 
and for 315/378 (83%) participants at 4–8 weeks, with 
similar completion rates for the three groups. Question-
naires documenting resource use during the admission 
for surgery were generally well completed (details not 
shown).
DISCuSSIOn
Almost two- thirds of eligible patients consented to take 
part and adherence to allocated dressing type was good 
immediately after wound closure and during participants’ 
follow- up. Therefore, it is concluded that a main trial of 
‘simple dressings’, ‘glue- as- a- dressing’ and ‘no dressings’ 
is feasible and acceptable to patients and health profes-
sionals. Implementation of the different randomisation 
schedules (before or after wound closure) was generally 
successful. Reference SSI assessments were performed 
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Figure 2 Consort flow diagram of participants in the Bluebelle study. *Wound Management Questionnaire and Wound 
Experience Questionnaire.
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Table 1 Outcomes related to the feasibility of identifying and recruiting patients
NBT: general 
surgery
NBT: obstetric 
surgery
UHBham: 
general 
surgery
UHBris: 
general 
surgery
WORC: 
general 
surgery Total
No. months open* 7 7 9 9 4 36
No. potentially eligible 
recorded/month (median, 
IQR)
14 (3.0–25.0) 27 (25.0–48.0) 71 (57.0–80.0) 21 (13.0–25.0) 10 (4.5–13.0) 142 (57.0–
152.0)
No. potentially eligible 
recorded by staff
96 230 558 196 35 1115
No. (%) potentially 
eligible confirmed eligible
90 (93.8) 205 (89.1) 469 (84.1) 154 (78.6) 34 (97.1) 952 (85.4)
No. (%) of eligible who 
were approached
87 (96.7) 126 (61.5) 317 (67.6) 136 (88.3) 33 (97.1) 699 (73.4)
No. (%) of eligible 
approached and 
consented†
65 (74.7) 81 (64.3) 120 (37.9) 127 (93.4) 22 (66.7) 415 (59.4)
*Nearest whole month.
†Not all consented patients were finally randomised.
NBT, North Bristol NHS Trust; UHBham, University Hospitals Birmingham NHS Foundation Trust; UHBris, University Hospitals Bristol NHS 
Foundation Trust; WORC, Worcestershire Acute Hospitals NHS Trust.
well although other follow- up assessments of SSI question-
naires were less satisfactory. Completeness of follow- up, 
however, was not the focus of the pilot study (foci were 
recruitment and adherence). It is expected that a future 
trial would combat these challenges using a complemen-
tary armamentarium of measures to enhance follow- up 
(reminders, text messages, telephone follow- up, etc).
Many previous RCTs have examined interventions 
to reduce SSI, although the quality and conduct of 
most studies is low and there is a lack of strategic feasi-
bility work.8–10 The Bluebelle study has addressed many 
of the key issues. Importantly, it demonstrates that a 
large, rigorous RCT could be done. In the participating 
centres there was, however, variation in rates of rando-
misation (37.9%–93.4%). Some of this variation is likely 
to be explained by the different approaches used to 
approaching and screening patients between hospitals. 
It may also reflect how the study was communicated 
by individuals at different centres. In a main trial, it is 
expected that training for recruitment and materials used 
to optimise recruitment will be available based on lessons 
learnt in this pilot. It is likely that a main two- group trial 
would address whether ‘no dressings’ are non- inferior to 
a simple dressing in terms of SSI; this is the comparison is 
of greatest value to the National Health Service.18 A main 
trial with three groups would be more efficient than a 
separate trial to test the superiority of ‘glue- as- a- dressing’ 
to simple dressings. Although basic/simple dressings are 
inexpensive, they are used in very high volumes. Evidence 
that a ‘no dressing’ strategy is non- inferior may result 
in significant savings for the health service. However, 
providing this evidence would likely require likely a very 
large trial (>10 000 participants) to exclude the possi-
bility of a small increase in the SSI rate in the no dressing 
group compared with the basic dressing group. Such a 
large trial would require an efficient design with elec-
tronic data capture and a well organised multidisciplinary 
clinical and academic team including patient partners. 
Since the conception of the Bluebelle study, there has 
been growing use of negative pressure wound therapy on 
primary wounds to reduce SSI. There is also increasing 
use of advanced dressings (with interactive properties). 
While these are of interest to the field, the focus of the 
proposed main Bluebelle trial is to establish whether ‘no 
dressing’ is non- inferior to standard dressings and to 
gain data to support the use of ‘glue- as- a- dressing’ on a 
primary surgical wound.
In the Bluebelle pilot RCT, there were contributions 
from surgical trainees as part of surgical research collabo-
ratives. As observed in other studies, these collaboratives 
helped the trial to recruit to time and target.20 21 Trainees 
were also involved in the study design (two trainees were 
grant coapplicants) and led and contributed to substudies. 
The involvement of surgical trainees in high- quality trials 
means that they can gain a research apprenticeship. This 
will equip their consultant practice with skills to engage in 
establishing evidence and implementing it as the results 
of trials become available. There were also complexities 
of working with surgical trainees, relating to the numbers 
of people involved and occasional confusion over respon-
sibilities. Centres were required to set up additional 
processes to streamline communication between the 
teams and trainees. It is recommended that major trials 
involving trainee collaboratives consider budgeting for 
additional administrative support to allow coordination 
of the efforts of the large numbers of people involved.
Although the study recruited to time and target, there 
were limitations with the response rates to follow up 
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Table 2 Demographics and clinical details of randomised participants by group
Simple dressing n=131 Glue as- a- dressing n=126 ‘No dressing’ n=131 Total n=388
Median age in years (IQR) 55 (35.9–65.3) 48 (32.3–66.2) 53 (36.4–68.2) 52 (34.7–66.9)
Female gender (%) 80/131 (61.1) 75/126 (59.5) 72/131 (55.0) 227/388 (58.5)
Median BMI (IQR)* 28 (24.5–31.8) 27 (24.2–32.0) 28 (24.6–31.0) 28 (24.3–31.6)
Ethnicity (%) white 120/128 (93.8) 105/119 (88.2) 116/127 (91.3) 341/374 (91.2)
Smoking history (%)
  Current smoker 16/131 (12.2) 22/125 (17.6) 22/130 (16.9) 60/386 (15.5)
  Ex- smoker >1 month 53/131 (40.1) 36/125 (28.8) 47/130 (36.2) 136/386 (35.2)
  Current steroids, PO/IV/IM (%) 15/131 (11.5) 4/126 (3.2) 6/131 (4.6) 25/388 (6.4)
  Diabetes, any type (%) 11/130 (8.5) 10/126 (7.9) 8/130 (6.2) 29/386 (7.5)
ASA class (%)
  1: Healthy, no medical 
problems
43/128 (33.6) 51/125 (40.8) 40/131 (30.5) 134/384 (34.9)
  2: Mild systemic disease 72/128 (56.3) 58/125 (46.4) 73/131 (55.7) 203/384 (52.9)
  3/4: Severe systemic disease 13/128 (10.2) 16/125 (12.8) 18/131 (13.7) 47/384 (12.2)
Wound closure (wounds/
patients)
  Sutures 240/121 (95.3) 240/117 (95.1) 229/117 (90.7) 709/355 (93.7)
  Clips 14/10 (9.9) 13/6 (6.1) 16/12 (11.5) 43/28 (9.2)
  Steristrips 20/9 (7.1) 1/1 (0.8) 7/5 (3.8) 28/15 (4.0)
  Glue (not planned) 4/2 (2.0) 2/2 (2.0) 4/2 (1.9) 10/6 (2.0)
Total no of wounds 278 256 256 790
Prophylactic antibiotics (%) 101/129 (78.3) 99/126 (78.6) 96/130 (73.8) 296/385 (76.9)
Infection risk of surgery (%)†
  Clean 46/131 (35.1) 49/126 (38.9) 44/131 (33.6) 139/388 (35.8)
  Clean- contaminated 81/131 (61.8) 72/126 (57.1) 81/131 (61.8) 234/388 (60.3)
  Contaminated/dirty 4/131 (3.1) 5/126 (4.0) 6/131 (4.6) 15/388 (3.9)
*Four missing data (simple, glue- as- a- dressing, ‘no dressing’, 2, 1, 1, respectively), elsewhere when a cell denominator is different to the 
number in a column header, the difference arises because of missing data for that variable.
†Classified by type and urgency of surgery.
ASA, American Society of Anesthesia;BMI, body mass index; IM, intramuscular;IV, intravenous; PO, per oral.
Table 3 Potential trial primary outcome by group
Simple 
dressing 
n=131
Glue as- a- 
dressing 
n=126
‘No 
dressing’ 
n=131 Total n=388
SSI (%)*
4–8 week reference
  None 80/97 (82.5) 83/98 (84.7) 90/107 (84.1) 253/302 (83.8)
  Superficial 14/97 (14.4) 14/98 (14.3) 17/107 (15.9) 45/302 (14.9)
  Deep 3/97 (3.1) 0/98 (0.0) 0/107 (0.0) 3/302 (1.0)
  Organ/
space
0/97 (0.0) 1/98 (1.0) 0/107 (0.0) 1/302 (0.3)
  Overall 17/92 (18.5) 16/90 (17.8) 18/99 (18.2) 51/281 (18.1)
*When the cell denominator is different to number in column header, the 
difference arises because of missing data for that variable.
SSI, surgical site infection.
assessments made by post. The logistics of obtaining the 
data were complex in this pilot study with three assess-
ments being made (a patient- completed SSI assessment; 
an observer- completed SSI assessment and an indepen-
dent face- to- face reference SSI assessment) and this 
required two members of staff. In a main trial, a single 
assessment would be required. It would also aim follow- up 
processes (scheduling of despatch and generation of ques-
tionnaires, etc) to be largely automated and for assess-
ments to be conducted electronically (manual processes 
were used in this pilot RCT). It is, therefore, believed that 
it is possible to improve the response rate substantially 
and we have recommended to the funder that a future 
main trial be required to demonstrate a high response 
rate in an internal pilot phase. In the main trial, it may 
also be possible to supplement questionnaire data about 
SSIs with wound photography. Further work is ongoing 
exploring this.
In summary, this pilot RCT has informed the feasibility, 
design and likely conduct of a future main trial of different 
dressing strategies, including ‘no dressing’.16 A future 
three group trial could jointly address the hypotheses 
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Table 4 Questionnaire response rates for SSI assessments, wound experience and management questionnaires and EQ- 5D- 
5L by group and overall
Simple dressing 
n=131 (%)
Glue as- a- dressing 
n=126 (%)
‘No dressing’ n=131 
(%) Total n=388 (%)
SSI reference assessment 97/127 (76.4) 98/122 (80.3) 107/128 (83.6) 302/377 (80)
Patient reported SSI assessment 
(WHQ)
84/127 (66.1) 85/122 (69.7) 87/129 (67.4) 256/378 (68)
Observer reported SSI assessment 
(WHQ)
93/127 (73.2) 92/122 (75.4) 101/128 (78.9) 286/377 (76)
Wound questionnaires
  Experience 118/131 (90.1) 119/125 (95.2) 118/129 (91.5) 355/385 (92.2)
  Management 118/131 (90.1) 121/125 (96.8) 119/129 (92.2) 358/385 (93.0)
EQ- 5D- 5L
  Baseline 128/131 (97.7) 126/126 (100) 131/131 (100) 385/388 (99.2)
  15 days 90/128 (70.3) 87/125 (69.6) 92/129 (71.3) 269/383 (70.4)
  4–8 weeks 84/127 (66.1) 78/122 (63.9) 80/128 (62.5) 242/377 (64.2)
EQ- 5D- 5L, EuroQoL- five- dimension- five- level; SSI, surgical site infection; WHQ, Wound Healing Questionnaire.
that: (1) ‘glue- as- a- dressing’ reduces the risk of SSI 
compared with ‘simple dressing’ (superiority of glue- as- a- 
dressing) and (2) ‘no dressing’ does not increase the risk 
of SSI (non- inferiority of ‘no dressing’). In such a trial, it 
is proposed that the primary outcome should be a combi-
nation of information about SSI collected at discharge (as 
in this study) and SSI ascertained by the patient- reported 
questionnaire (WHQ), providing that a better response 
rate can be obtained and a cut- off score on WHQ can 
be established to define SSI. A conventional ‘reference’ 
SSI assessment would be impracticable as the primary 
outcome in a main trial because of the high cost of face- 
to- face assessments. In view of the observed rates of SSI 
in this pilot RCT and other studies, such a trial will need 
to be sizeable (>10 000 patients) to confidently exclude 
true differences in SSI rate. Another issue to consider for 
a main trial is the best time to disclose dressing alloca-
tion (before or after wound closure). It is concluded that 
the pilot RCT and feasibility work undertaken within the 
Bluebelle study has been valuable to inform surgical RCT 
design. This approach is recommended for other clinical 
questions with challenges in recruitment and outcome 
assessment before embarking on a main trial.
Contributors The Bluebelle study group consists of the co- investigators and 
other members. Full details of individuals contributions are as follows: Co- 
investigators: Mark Woodward: contributing experience of not using dressings on 
surgical wounds in children who have had abdominal surgery. Nicky J Welton: 
responsible for conducting a value for information analysis about a full- scale 
trial. Andrew D Torrance: recruited patients for the qualitative interviews and 
contributed to development of the SSI measure. Leila Rooshenas: responsible for 
design and delivery of qualitative studies in the pilot trial, to inform trial design 
and test various aspects of feasibility. Chris Rogers: responsibile for estimating 
the target sample size and planning the quantitative analyses. Barnaby C Reeves: 
responsible for the design and methods of the Bluebelle feasibility study. Anne 
Pullyblank: responsible for set up and delivery in one participating centre of the 
study in general surgery. Thomas D Pinkney: responsible for one participating 
centre recruiting patients having abdominal surgery and contributed to the overall 
study design and development of the WHQ. Jonathan M Mathers: responsibile for 
co- design and delivery of the qualitative studies in the pilot trial. Richard Lovegrove: 
responsibile for one participating centre recruiting patients having abdominal 
surgery. Robert J Longman: responsibile for one participating centre recruiting 
patients having abdominal surgery. Rachael Gooberman- Hill: responsibility for 
patient and public involvement. Jo C Dumville: updated the Cochrane review 
of wound dressings to consider the use of tissue adhesives as a dressing. Tim 
Draycott: responsibility for one participating centre recruiting women having 
caesarean section. Jenny L Donovan: responsibility for supervising qualitative 
research. Joanna Coast: responsibility for supervising health economic aspects 
of the pilot trial. Melanie J Calvert: advising and supporting development of the 
WHQ and other outcome measures, the feasibility study and pilot trial design. Jane 
M Blazeby: Chief investigator responsible for overall conception and the design 
of the Bluebelle feasibility study. Natalie S Blencowe: led the survey of wound 
dressings and contributed to the design of the pilot trial, the development of WHQ 
and other outcome measures. Lazaros Andronis: responsibility for carrying out 
health economic aspects of the pilot trial. Other study group members: Dimitrios 
Siassakos: responsible for implementation of the study protocol in one centre. 
Caroline Pope: assisted with setting up and managing the trial. Tom Milne: 
researched definitions of simple, complex and no dressings under supervision. 
Contributed to the development of the WHQ. Christel McMullan: responsible for 
qualitative data collection /analysis in the pilot trial. Rhiannon Macefield: led the 
development and validation of the Wound Healing Questionnaire. Rosie Harris: 
responsible for preparing the pilot RCT statistical analysis plan. Lucy Ellis: prepared 
the first protocol for the pilot trial. Daisy Elliott: led the development of other study 
outcome measures. Madeleine Clout: assisted in managing the pilot trial and 
member of the writing group for this manuscript. Benjamin E Byrne: helped set 
up one participating centre including designing training materials and improving 
study design and processes. Kate Ashton: managed the pilot trial, including site 
initiation visits and the second protocol amendment.The following members 
identified and recruited patients and contributed to study delivery in local trust: 
Benjamin R Waterhouse, Sean Strong, William Seligman, Lloyd Rickard, Samir 
Pathak, Anwar Owais, Jamie O'Callaghan, Stephen O'Brien, Dmitri Nepogodiev, 
Khaldoun Nadi, Charlotte Murkin, Tonia Munder, David Messenger, Matthew Mason, 
Morwena Marshall, Jessica Lloyd, Jeffrey Lim, Kathryn Lee, Vijay Korwar, Daniel 
Hughes, George Hill, Mohammed Hamdan, Hannah Gould Brown, James Glasbey, 
Caroline Fryer, Simon Davey, David Cotton, Oliver D Brown, Katarzyna D Bera, 
Joanne Bennett, Richard Bamford, Danya Bakhbakhi, Muhammad Atif, Elizabeth 
Armstrong, Piriyankan Ananthavarathan. The following nurses and administrative 
staff contributed to study delivery and management within the local research 
teams: Rebecca Houlihan, Joanna Nicklin, Louise Flintoff, Jo Chambers, Karen 
Bobruk (University Hospitals Bristol NHS Foundation Trust). Helen Cheshire, Suriya 
Kirkpatrick, Louise Solomon, Alice Jarvie, Cathy Winter, Clementine Skilton, Susan 
Hughes, Michelle Mayer, Jade Knowlden, Mary Alvarez, Sherrie Villis (North Bristol 
NHS Trust). Kelly Hollier, Natalie Jackson, Victoria Hardy, David Tyrell, Sharon Garner, 
 o
n
 February 7, 2020 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2019-030615 on 12 January 2020. Downloaded from 
8 Blazeby J. BMJ Open 2020;10:e030615. doi:10.1136/bmjopen-2019-030615
Open access 
Arlo Whitehouse (University Hospitals Birmingham NHS Foundation Trust). Caroline 
Alton, Jessica Thrush, Julie Wollaston (Worcestershire Acute Hospitals NHS Trust). 
Katrina Hurley (Bristol Dental Hospital, Bristol). David Hutton, Helen Talbot (Clinical 
Trials and Evaluation Unit, Department of Translational Health Sciences, Bristol 
Medical School, Bristol). Laura Magill (University of Birmingham Clinical Trials Unit, 
Birmingham). Trudie Young (University of Glamorgan, Glamorgan). Katy Chalmers, 
Barry Main (Department of Population Health Sciences, Bristol Medical School, 
Bristol). 
Funding The Bluebelle study was funded by the National Institute for Health 
Research HTA Programme (project number 12/200/04) and supported by the MRC 
ConDuCT- II Hub for Trials Methodology Research (Collaboration and innovation for 
Difficult and Complex randomised controlled Trials In Invasive procedures - MR/
K025643/1). JLD and JB are NIHR senior investigators. JB is partially funded 
by the NIHR Biomedical Research Centre at University Hospitals Bristol NHS 
Foundation Trust and University of Bristol. MJC is partly funded by the NIHR 
Birmingham Biomedical Research Centre and the NIHR Surgical Reconstruction 
and Microbiology Research Centre at the University Hospitals Birmingham NHS 
Foundation Trust and the University of Birmingham. This study was designed and 
delivered in collaboration with the Clinical Trials and Evaluation Unit (CTEU), a 
UKCRC registered clinical trials unit which, as part of the Bristol Trials Centre, is in 
receipt of National Institute for Health Research CTU support funding.
Disclaimer The funders had no role in the design of the study, the collection and 
analyses of the data, the interpretation of the findings or in drafting this manuscript.
Competing interests None declared.
Patient consent for publication Not required.
ethics approval Full research ethics approval was obtained from the Frenchay 
Research Ethics Committee on the 24th February 2015 (REC reference 15/
SW/0008).
Provenance and peer review Not commissioned; externally peer reviewed.
Data availability statement Data are available on reasonable request. Requests 
can be made to  bluebelle_ trial@ bristol. ac. uk. Anonymised individual participant 
data is available for secondary research, conditional on assurance that the 
proposed use of the data is compliant with the MRC Policy on Data Sharing 
regarding scientific quality, ethical requirements and value for money.
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits 
others to copy, redistribute, remix, transform and build upon this work for any 
purpose, provided the original work is properly cited, a link to the licence is given, 
and indication of whether changes were made. See: https:// creativecommons. org/ 
licenses/ by/ 4. 0/.
reFerenCeS
 1 Abbott TEF, Fowler AJ, Dobbs TD, et al. Frequency of surgical 
treatment and related Hospital procedures in the UK: a national 
ecological study using Hospital episode statistics. Br J Anaesth 
2017;119:249–57.
 2 National Nosocomial Infections Surveillance System. National 
nosocomial infections surveillance (NNIS) system report, data 
summary from January 1992 through June 2004, issued October 
2004. Am J Infect Control 2004;32:470–85.
 3 Health Protection Agency. Surveillance of surgical site infections in 
NHS hospitals in England 2011:1–32.
 4 Coello R, Charlett A, Wilson J, et al. Adverse impact of surgical site 
infections in English hospitals. J Hosp Infect 2005;60:93–103.
 5 Weber WP, Zwahlen M, Reck S, et al. Economic burden of surgical 
site infections at a European university hospital. Infect Control Hosp 
Epidemiol 2008;29:623–9.
 6 Blumetti J, Luu M, Sarosi G, et al. Surgical site infections after 
colorectal surgery: do risk factors vary depending on the type of 
infection considered? Surgery 2007;142:704–11.
 7 Betrán AP, Ye J, Moller A- B, et al. The increasing trend in caesarean 
section rates: global, regional and national estimates: 1990-2014. 
PLoS One 2016;11:e0148343.
 8 Dumville JC, Walter CJ, Sharp CA, et al. Dressings for the prevention 
of surgical site infection. Cochrane Database Syst Rev 2011;7.
 9 Dumville JC, Gray TA, Walter CJ, et al. Dressings for the 
prevention of surgical site infection. Cochrane Database Syst Rev 
2016;12:CD003091.
 10 Walter CJ, Dumville JC, Sharp CA, et al. Systematic review and 
meta- analysis of wound dressings in the prevention of surgical- site 
infections in surgical wounds healing by primary intention. Br J Surg 
2012;99:1185–94.
 11 Liu Z, Dumville JC, Norman G, et al. Intraoperative interventions for 
preventing surgical site infection: an overview of Cochrane reviews. 
Cochrane Database Syst Rev 2018;15.
 12 Rooshenas L, Bluebelle Study Group; Severn and Peninsula Audit 
and Research Collaborative for Surgeons; West Midlands Research 
Collaborative. Bluebelle study (phase a): a mixed- methods feasibility 
study to inform an RCT of surgical wound dressing strategies. 
BMJ Open 2016;6:e012635. Erratum in: BMJ Open. 2018 Feb 
10;8(2):e012635corr1. PMID: 27660321.
 13 Severn and Peninsula Audit and Research Collaborative for Surgeons 
(SPARCS) and West Midlands Research Collaborative (WMRC) on 
behalf of the Bluebelle Study Group. Feasibility work to inform the 
design of a randomized clinical trial of wound dressings in elective 
and unplanned abdominal surgery. Br J Surg 2016;103:1738–44.
 14 Elliott D, Group BS. Developing outcome measures assessing wound 
management and patient experience: a mixed methods study. BMJ 
Open 2017;7:e016155.
 15 Macefield RC, Reeves BC, Milne TK, et al. Development of a single, 
practical measure of surgical site infection (SSI) for patient report or 
observer completion. J Infect Prev 2017;18:170–9.
 16 Reeves BC, Andronis L, Blazeby JM, et al. A mixed- methods 
feasibility and external pilot study to inform a large pragmatic 
randomised controlled trial of the effects of surgical wound dressing 
strategies on surgical site infections (Bluebelle phase B): study 
protocol for a randomised controlled trial. Trials 2017;18:401.
 17 Herdman M, Gudex C, Lloyd A, et al. Development and preliminary 
testing of the new five- level version of EQ- 5D (EQ- 5D- 5L). Qual Life 
Res 2011;20:1727–36.
 18 Reeves BC, Rooshenas L, Macefield RC, et al. Three wound- 
dressing strategies to reduce surgical site infection after abdominal 
surgery: the Bluebelle feasibility study and pilot RCT. Health Technol 
Assess 2019;23:1–166.
 19 Bluebelle Study Group. Validation of the Bluebelle wound healing 
questionnaire (WHQ) for assessment of surgical site infection in close 
primary wounds after hospital discharge. Br J Surg 2019;106:226–35.
 20 Pinkney TD, Calvert M, Bartlett DC, et al. Impact of wound edge 
protection devices on surgical site infection after laparotomy: 
multicentre randomised controlled trial (ROSSINI trial). BMJ 
2013;347:f4305.
 21 Nepogodiev D, Chapman SJ, Kolias AG, et al. National surgical 
research collaborative. The effect of trainee research collaboratives in 
the UK. Lancet Gastroenterol Hepatol 2017;2:247–8.
 o
n
 February 7, 2020 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2019-030615 on 12 January 2020. Downloaded from 
